Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Signals from Rusty Joints

MP3 WAV

  • Perhaps you suffer from rheumatoid arthritis or your mother or an aunt does. The autoimmune disease, RA for short, affects one and a half million Americans, and most of them are women. Their immune system which protects them from infections also causes chronic inflammation that can damage organs, but especially flexible joints.

    Scientists have been looking for ways to block this response and recently found one. Their work focused on a group of cells called macrophages. Macrophages are in every tissue in our body and are crucial to our immune response. Thus they're also in the synovial fluid which cushions our joints.

    In people with RA, the macrophages in this lubricating fluid have elevated levels of a family of proteins called Toll-Like Receptors or TLRs. TLRs are critical in early immune response by sensing invading pathogens in the body, but in RA they end up targeting the joint itself.

    In a previous study, blocking TLR signaling seemed to improve patients' symptoms. In the new study researchers also focused on TLRs but this time on the molecules that process signals from TLRs.

    This molecule is called IRE1alpha. Mice without this molecule had reduced inflammation and were protected from developing rheumatoid arthritis. Normal mice treated with a drug that inhibits this molecule also did not get RA.

    These results show TLR signaling may indeed play a key role in this disease. If scientists can replicate the results in humans, would they be protected from RA yet be more susceptible to infections? Much has yet to be worked out but if they could, the treatment would improve the lives of millions.

More Information

Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis
Scientific journal article about this study, by Dr. Quan Qiu, et al.

Rheumatoid arthritis
Information provided by the esteemed Mayo Clinic

Toll-Like Receptors: Sensors that Detect Infection
"The discovery of microbial-sensing proteins called Toll-like receptors is transforming our understanding of the body's response to infection."

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.